Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals.
Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals. Ann Surg Oncol. 2012 Feb; 19(2):357-64.